Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Oct 24 - Oct 29
For further information, we recommend consulting specialist literature or websites before placing an order
Many people in these communities already compare prescription costs each year, and this new program adds another item to review
Key Milestones Timeline Eli Lillys Strategic Context Retatrutides development occurs within Eli Lillys broader metabolic disease portfolio, which also includes tirzepatide (approved as Mounjaro for type 2 diabetes and Zepbound for obesity) and orforglipron (an oral GLP-1R agonist in Phase 3 development)
If you are ready to see whether a personalized program is the right fit, you can take the free assessment quiz
US$ 29.26
US$ 29.55
US$ 27.95
.jpeg)
US$ 26.62
US$ 29.90
US$ 21.33
US$ 21.02
US$ 20.13
